JAK2 and myeloproliferative neoplasm: Within individual MPN subtypes, JAK2 allelic burden was associated with a higher incidence of MPN symptoms, splenomegaly and stimulated haematopoiesis (Kerguelén et al., 2012; Vannucchi et al., 2011).